Robert Escher

1.1k total citations
21 papers, 352 citations indexed

About

Robert Escher is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Robert Escher has authored 21 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Internal Medicine. Recurrent topics in Robert Escher's work include Venous Thromboembolism Diagnosis and Management (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Acute Myeloid Leukemia Research (4 papers). Robert Escher is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Acute Myeloid Leukemia Research (4 papers). Robert Escher collaborates with scholars based in Switzerland, Australia and Germany. Robert Escher's co-authors include Hamish S. Scott, Joëlle Michaud, A Greco, Michael T. McNamara, Catherine Carmichael, Daniel Hayoz, Lucia Mazzolai, Thomas Baldi, Drahomir Aujesky and Marc Husmann and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Thrombosis and Haemostasis and BMC Genomics.

In The Last Decade

Robert Escher

20 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Escher Switzerland 10 113 96 81 75 73 21 352
Nicolai A. Kittan United States 14 149 1.3× 21 0.2× 12 0.1× 24 0.3× 48 0.7× 19 500
Sami Guermazi Tunisia 10 67 0.6× 99 1.0× 35 0.4× 42 0.6× 174 2.4× 33 357
Ashish Jain United States 9 62 0.5× 15 0.2× 5 0.1× 51 0.7× 22 0.3× 27 348
Aditi Shastri United States 10 56 0.5× 51 0.5× 15 0.2× 22 0.3× 89 1.2× 39 344
Patrizia Pignoloni Italy 13 70 0.6× 8 0.1× 27 0.3× 48 0.6× 131 1.8× 15 438
Elizabeth A. Stewart United Kingdom 11 168 1.5× 13 0.1× 17 0.2× 52 0.7× 98 1.3× 15 576
Debra J. Endean United States 9 61 0.5× 48 0.5× 22 0.3× 12 0.2× 208 2.8× 9 340
Tanjina Akter United States 9 70 0.6× 19 0.2× 29 0.4× 19 0.3× 22 0.3× 23 344
Carl D. Sammarco United States 12 45 0.4× 5 0.1× 116 1.4× 37 0.5× 25 0.3× 16 350
Darren E. Whittemore United States 8 44 0.4× 4 0.0× 13 0.2× 64 0.9× 6 0.1× 15 303

Countries citing papers authored by Robert Escher

Since Specialization
Citations

This map shows the geographic impact of Robert Escher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Escher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Escher more than expected).

Fields of papers citing papers by Robert Escher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Escher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Escher. The network helps show where Robert Escher may publish in the future.

Co-authorship network of co-authors of Robert Escher

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Escher. A scholar is included among the top collaborators of Robert Escher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Escher. Robert Escher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Margini, Cristina, et al.. (2023). Fever of Unknown Origin, a Vascular Event, and Immunosuppression in Tick-Endemic Areas: Think About Neoehrlichiosis. Cureus. 15(6). e40617–e40617. 2 indexed citations
3.
Méan, Marie, Neal Breakey, Odile Stalder, et al.. (2023). Thrombophilia and outcomes of venous thromboembolism in older patients. Research and Practice in Thrombosis and Haemostasis. 7(1). 100015–100015. 3 indexed citations
4.
Spirk, David, Tim Sebastian, Stefano Barco, et al.. (2020). Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER). Thrombosis and Haemostasis. 121(5). 641–649. 9 indexed citations
5.
Eijer, Henk, et al.. (2020). Septic arthritis of the knee due to <i>Pantoea</i> <i>agglomerans</i>: look for the thorn. Journal of Bone and Joint Infection. 6(3). 51–55. 5 indexed citations
6.
Escher, Robert, et al.. (2019). Thrombophlebitis hiding under a KILT – case report on 40 years long-term follow-up of neonatal renal vein thrombosis. BMC Pediatrics. 19(1). 183–183. 5 indexed citations
7.
Spirk, David, Tim Sebastian, Martin Banyai, et al.. (2019). Venous Thromboembolism and Renal Impairment: Insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER). Seminars in Thrombosis and Hemostasis. 45(8). 851–858. 7 indexed citations
8.
9.
Aujesky, Drahomir, Jürg H. Beer, Lucia Mazzolai, et al.. (2016). Rivaroxaban for the treatment of venous thromboembolism. Thrombosis and Haemostasis. 116(9). 472–479. 36 indexed citations
10.
Spirk, David, Drahomir Aujesky, Anna K. Stuck, et al.. (2016). Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER). Seminars in Thrombosis and Hemostasis. 42(6). 642–649. 22 indexed citations
11.
Studer, U., et al.. (2011). Atypical presentation of Behçet’s disease with central nervous system involvement successfully treated with infliximab. Rheumatology International. 32(5). 1431–1435. 3 indexed citations
12.
Hlushchuk, Ruslan, Martin Ehrbar, Beata Styp‐Rekowska, et al.. (2011). Decrease in VEGF Expression Induces Intussusceptive Vascular Pruning. Arteriosclerosis Thrombosis and Vascular Biology. 31(12). 2836–2844. 33 indexed citations
13.
Michaud, Joëlle, Ken Simpson, Robert Escher, et al.. (2008). Integrative analysis of RUNX1 downstream pathways and target genes. BMC Genomics. 9(1). 363–363. 97 indexed citations
14.
Escher, Robert, et al.. (2008). Advanced Lemierre Syndrome Requiring Surgery. Infection. 36(5). 495–496. 9 indexed citations
15.
Escher, Robert, et al.. (2008). Antiaggregatory and proangiogenic effects of a novel recombinant human dual specificity anti‐integrin antibody. Journal of Thrombosis and Haemostasis. 7(3). 460–469. 3 indexed citations
16.
Escher, Robert, Catherine Carmichael, Ram Suppiah, et al.. (2007). A pedigree with autosomal dominant thrombocytopenia, red cell macrocytosis, and an occurrence of t(12:21) positive pre-B acute lymphoblastic leukemia. Blood Cells Molecules and Diseases. 39(1). 107–114. 2 indexed citations
17.
Escher, Robert, Fitsum Hagos, Catherine Carmichael, et al.. (2004). Chromosome band 16q22‐linked familial AML: Exclusion of candidate genes, and possible disease risk modification by NQO1 polymorphisms. Genes Chromosomes and Cancer. 41(3). 278–282. 3 indexed citations
18.
Michaud, Joëlle, Hamish S. Scott, & Robert Escher. (2003). AML1 Interconnected Pathways of Leukemogenesis. Cancer Investigation. 21(1). 105–136. 33 indexed citations
19.
Escher, Robert, Monique Vogel, Geneviève Escher, et al.. (2002). Recombinant Anti-idiotypic Antibodies Inhibit Human Natural Anti-glycoprotein (GP)IIb/IIIa Autoantibodies. Journal of Autoimmunity. 18(1). 71–81. 4 indexed citations
20.
Greco, A, et al.. (1991). Spin-Echo and STIR MR Imaging of Sports-Related Muscle Injuries at 1.5 T. Journal of Computer Assisted Tomography. 15(6). 994–999. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolai A. Kittan Breakdown of academic impact, for papers by Sami Guermazi Breakdown of academic impact, for papers by Ashish Jain Breakdown of academic impact, for papers by Aditi Shastri Breakdown of academic impact, for papers by Patrizia Pignoloni Breakdown of academic impact, for papers by Elizabeth A. Stewart Breakdown of academic impact, for papers by Debra J. Endean Breakdown of academic impact, for papers by Tanjina Akter Breakdown of academic impact, for papers by Carl D. Sammarco Breakdown of academic impact, for papers by Darren E. Whittemore
Rankless by CCL
2026